News
Why Illumina Stock Zoomed Higher on Thursday
A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
Investors are enjoying the ongoing bull run. The S&P 500 and Nasdaq Composite recently hit all-time highs. Though that's pretty exciting, bull markets don't last forever. Equities that can perform
EQS-Adhoc: STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR
AEVIS VICTORIA SA (AEVS.SW) – Publication of the 2023 revenue
Humana and DUOS Launch Groundbreaking Initiative Enhancing Care for U.S. Veteran Seniors
Humana Inc. (NYSE: HUM) and DUOS, a technology-enabled service provider announces a new collaborative program to enhance the healthcare experience and improve health outcomes for Louisiana Veteran
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today
How Rivian Can Not Only Survive but Thrive in 2024
A storm has been brewing around the electric vehicle (EV) industry. The storm is a mix of high interest rates that make consumers hesitant to purchase vehicles, charging infrastructure challenges, a
Is Rithm Capital Stock a Buy?
Dividend stocks can be an excellent source of passive income, and Rithm Capital (NYSE: RITM) is one of the highest-yielding dividend stocks you can buy today. Its 9.1% dividend yield makes it an
Rivian Automotive Stock Has Nearly 100% Upside, According to 1 Wall Street Analyst
Rivian Automotive (NASDAQ: RIVN) investors had a traumatic Thursday, as news of rival Fisker's probable restructuring sent electric car investors scurrying for cover. However, no sooner had markets
1 Wall Street Analyst Warns That Rivian Stock Could Drop to $9
Last week, Rivian Automotive (NASDAQ: RIVN) unveiled not one, but two new prospective electric vehicles: The slimmed-down R2 electric SUV and an unexpected R3 electric hatchback. But investor
AEVIS VICTORIA SA - Fabrice Zumbrunnen to become CEO of AEVIS VICTORIA SA as of May 1, 2024
2 Medical Device Stocks to Buy Hand Over Fist in March
A good way to invest in the healthcare industry's continued growth is by targeting businesses that make medical devices. Such equipment aids physicians in surgery, helps patients recover, and can
Rivian Exposed: R2 Launch Shows Big Problems
Rivian's (NASDAQ: RIVN) biggest challenge right now is cash. The company's cash burn is unsustainable while building out R2 and R3 capacity, which is why management announced reduced capital
Why Victoria's Secret Stock Plummeted Today
Shares of Victoria's Secret (NYSE: VSCO) plummeted 29.7% on Thursday after the lingerie, clothing, and beauty-products retailer announced reasonably solid quarterly results but followed with
EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom – the first glucose
Can the New R2 Save Rivian?
Rivian (NASDAQ: RIVN) is unveiling the R2, its next-generation vehicle, this week, and a lot is riding on the launch. A $5 billion plant in Georgia will construct the vehicle and, if successful
3 High-Yield S&P 500 Dividend Stocks Down More Than 28% to Buy Now and Hold at Least a Decade
Rising tides don't always lift all boats. The S&P 500 index reached new all-time highs several times since 2024 began, but many of its components have not participated in the rally.
With most
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced compelling new clinical evidence supporting the use of Dexcom
Plug Power Stock Has 16% Upside, According to 1 Wall Street Analyst
From the start of the year through the end of trading last week, Plug Power (NASDAQ: PLUG) stock has vastly underperformed the market. Whereas the S&P 500 rose 7.4% during this time frame, share
Why Plug Power Stock Surged 13.7% Thursday Morning
Plug Power (NASDAQ: PLUG) stock kicked off Thursday on a high note, surging 13.7% in early-morning trading. An analyst upgrade just ahead of earnings is fueling investor interest in the hydrogen
Why Illumina Stock Mashed the Market on Monday
Gene-sequencing stock Illumina (NASDAQ: ILMN) was a standout in the biotech sector Monday, with its share-price rise convincingly beating the S&P 500 index. Investors were cheered by a stock buy
If You Invested $10,000 in Medtronic in 2019, This Is How Much You Would Have Today
For seasoned healthcare investors, Medtronic (NYSE: MDT) needs no introduction. The medical device specialist has been around for decades, successfully navigating one of the most highly regulated
Could Eli Lilly Stock Help You Become a Millionaire?
Eli Lilly (NYSE: LLY) has been on a tear this past year, rising up to become the most valuable healthcare stock in the world. It soared past UnitedHealth Group and other top healthcare companies in
Why Nevro Stock Lagged the Market on Thursday
Specialty medical device maker Nevro (NYSE: NVRO) didn't make for an inspiring investment on Thursday. Its stock price dipped marginally following the company's release of its fourth-quarter